To date, several biomarkers (PD-L1 expression, tumor-infiltrating lymphocytes, mutational burden, immune gene signatures, etc.)have been proposed, even if they are not always predictive alone due to lack of sensibility or sensitivity [62]. The gene discussed is CD274; the disease is neoplasm.